Zydus Healthcare

Flu season starts, but demand for cough-cold meds remains weak

Impact in US among the worst in the past 10 years

Zydus Life launches generic version of Sitagliptin for type 2 diabetes

Zydus Lifesciences Ltd on Friday said it has launched the generic version of sitagliptin in India under the brand names Sitaglyn and Siglyn to address type 2 diabetes.

Zydus Lifesciences' chairman appointed as director in RBI's board

Zydus Lifesciences on Tuesday said its chairman Pankaj R Patel has been appointed as a part time non-official director in the central board of the Reserve Bank of India (RBl). The Appointments Committee of the Cabinet (ACC) has approved the proposal of appointment of Patel for a period of four years from the date of notification of his appointment, or until further orders, whichever is earlier, the drug maker said in a statement. Patel is already on the board of various institutions, including Invest India, Member of the Mission Steering Group (MSG) -- the highest policy making and steering body constituted under National Health Mission (NHM), and of the Drug Technical Advisory Board by the ministry of health & family welfare, it added. He is also the chairman of the Board of Governors and Society, IIM, Udaipur and a member of the Board of Governors of the Indian Institute of Management (IIM), Ahmedabad. Patel was also the president of the Federation of Indian Chamber of Commerce

Zydus Lifesciences gets USFDA nod for generic drug to treat chest pain

Zydus Lifesciences on Wednesday said it has received approval from the US health regulator to market Nitroglycerin Sublingual tablets, used to treat chest pain, in the American market.

Zydus to sell two brands to PE firm True North's portfolio company

Both drugs, Mifegest Cytolog are used for medical termination of pregnancy

Zydus Animal Health buyout catapults Multiples into the big league

Multiples' deal ticket size in the first fund was only $30 million and in the second around $50 million

Zydus Cadila gets USFDA nod for cancer, high blood pressure treatment drug

Drug firm Zydus Cadila on Thursday said it has received final approval from the US health regulator to market Ibrutinib Capsules, used to treat certain cancers

Aurobindo, Zydus, Jubilant, others recall various products in US market

Indian drug firms like Marksans Pharma, Aurobindo Pharma, Zydus and Jubilant are recalling products in the US market, as per the latest enforcement report by the USFDA

Zydus Healthcare launches anti-diabetic Dapagliflozin drug at cheap prices

The company has launched its Dapagliflozin tablets in the strengths of 10 mg and 5 mg priced at ₹17 and ₹14

Zydus Cadila launches cheap oral anti-diabetic tablets after patent expires

With a patient population of almost 77 million diabetics in India, access to affordable therapy is vital for the effective management of the disease, the statement said.

Zydus Healthcare moves India marketing operations to Mumbai

Zydus Healthcare is a wholly owned subsidiary of Cadila Healthcare

Zydus Healthcare buys Mumbai office property for Rs 172 cr

It bought Walia Business Park building on Western Express Highway in Goregaon East

Zydus Healthcare buys 2 ANDAs from Teva Pharmaceutical

Estimated market size of the two ANDAs put together is nearly $200 million, the company said